Forget me not: Novel target shows promise in treating Alzheimer's and related dementias

by Matthew Greseth,Medical University of South CarolinaThe cytotoxic tau isomer (cis P-tau; red) is partially colocalized with tau oligomers (green; top) and tau tangles (green; bottom) in Alzhe

Updated on: April 29,2024

Forget me not: Novel target shows promise in treating Alzheimer's and related dementias

by Matthew Greseth,Medical University of South CarolinaThe cytotoxic tau isomer (cis P-tau; red) is partially colocalized with tau oligomers (green; top) and tau tangles (green; bottom) in Alzhe

Updated on:April 29,2024

Education may be protective for people with gene for familial early onset Alzheimer's

by American Academy of NeurologyCredit: CC0 Public DomainEven for people who carry the gene for early onset Alzheimer's disease, more years of education may slow the development of beta-amylo

Updated on: June 24,2024

Education may be protective for people with gene for familial early onset Alzheimer's

by American Academy of NeurologyCredit: CC0 Public DomainEven for people who carry the gene for early onset Alzheimer's disease, more years of education may slow the development of beta-amylo

Updated on:June 24,2024

Researchers discover a new face-detecting brain circuit

byNational Eye InstituteGongchen Yu, Ph.D., Leor Katz, Ph.D., and Richard Krauzlis, Ph.D. Credit: Dustin Hays, National Eye InstituteScientists at the National Institutes of Health (NIH) have un

Updated on: July 05,2024

Researchers discover a new face-detecting brain circuit

byNational Eye InstituteGongchen Yu, Ph.D., Leor Katz, Ph.D., and Richard Krauzlis, Ph.D. Credit: Dustin Hays, National Eye InstituteScientists at the National Institutes of Health (NIH) have un

Updated on:July 05,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on: April 01,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on:April 01,2024

Study finds repetitive high concentration capsaicin patch applications beneficial for nerve pain

FEBRUARY 7, 2024byWileyCredit: CC0 Public DomainCapsaicin, derived from hot chili pepper plants, has been used to treat various types of pain, and a high concentration capsaicin patch (HCCP) is

Updated on: March 28,2024

Study finds repetitive high concentration capsaicin patch applications beneficial for nerve pain

FEBRUARY 7, 2024byWileyCredit: CC0 Public DomainCapsaicin, derived from hot chili pepper plants, has been used to treat various types of pain, and a high concentration capsaicin patch (HCCP) is

Updated on:March 28,2024

Pre-TBI headache affects diagnosis of posttraumatic headache

Individuals with headache before traumatic brain injury (TBI) are less likely to receive a diagnosis of posttraumatic headache (PTH), according to a study published online May 20 inHeadache.Zach

Updated on: February 05,2024

Pre-TBI headache affects diagnosis of posttraumatic headache

Individuals with headache before traumatic brain injury (TBI) are less likely to receive a diagnosis of posttraumatic headache (PTH), according to a study published online May 20 inHeadache.Zach

Updated on:February 05,2024

Beyond plaques and tangles: Genetic variation may increase risk of cognitive decline

by American Academy of NeurologyCredit: CC0 Public DomainA genetic variation in some people may be associated with cognitive decline that can't be explained by deposits of two key proteins as

Updated on: May 13,2024

Beyond plaques and tangles: Genetic variation may increase risk of cognitive decline

by American Academy of NeurologyCredit: CC0 Public DomainA genetic variation in some people may be associated with cognitive decline that can't be explained by deposits of two key proteins as

Updated on:May 13,2024

Understanding the how and why of preterm brain injury

by Rob Clancy,Hudson Institute of Medical ResearchRepresentative images of NeuN- and MAP2-positive cells in the cortical gray matter (cortex; Layer V) and caudate. Scale bar represents 50μ

Updated on: September 23,2024

Understanding the how and why of preterm brain injury

by Rob Clancy,Hudson Institute of Medical ResearchRepresentative images of NeuN- and MAP2-positive cells in the cortical gray matter (cortex; Layer V) and caudate. Scale bar represents 50μ

Updated on:September 23,2024

Brain stimulation treatment may improve depression, anxiety in older adults

byUniversity of FloridaCredit: Pixabay/CC0 Public DomainA noninvasive brain stimulation treatment improved depression and anxiety symptoms among older adults in a new University of Florida-led&n

Updated on: April 28,2024

Brain stimulation treatment may improve depression, anxiety in older adults

byUniversity of FloridaCredit: Pixabay/CC0 Public DomainA noninvasive brain stimulation treatment improved depression and anxiety symptoms among older adults in a new University of Florida-led&n

Updated on:April 28,2024

COVID-19: Advice for caring for people with Alzheimer's disease, mild cognitive impairment

by From Mayo Clinic News NetworkCredit: CC0 Public DomainWith the COVID-19 pandemic at the forefront of daily life, how much information should you share with a loved one who has Alzheimer's disea

Updated on: March 26,2024

COVID-19: Advice for caring for people with Alzheimer's disease, mild cognitive impairment

by From Mayo Clinic News NetworkCredit: CC0 Public DomainWith the COVID-19 pandemic at the forefront of daily life, how much information should you share with a loved one who has Alzheimer's disea

Updated on:March 26,2024

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on: November 11,2024

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on:November 11,2024

Alzheimer's and dementia: Understand wandering and how to address it

by From Mayo Clinic News NetworkCredit: CC0 Public DomainWandering and becoming lost is common among people with Alzheimer's disease or other disorders causing dementia. This behavior can happen i

Updated on: April 20,2024

Alzheimer's and dementia: Understand wandering and how to address it

by From Mayo Clinic News NetworkCredit: CC0 Public DomainWandering and becoming lost is common among people with Alzheimer's disease or other disorders causing dementia. This behavior can happen i

Updated on:April 20,2024